Aevum Zenth / Divisions / Health Sciences

Zenth Health Sciences

Integrating pharmaceutical innovation, precision genomics, advanced medical devices, and global care networks to redefine modern healthcare delivery and patient outcomes across 45 nations.

Active Clinical Trials: 342 | FDA Approvals: 18 | Global Partners: 120+
Division President Dr. Elena Vance, MD, PhD
Annual R&D Spend $3.2 Billion
Care Facilities 89 Hospitals & Clinics
Regulatory Status ISO 13485 | FDA | EMA | NMPA Certified

Operational Overview

A vertically integrated health ecosystem spanning discovery to delivery.

Pharmaceutical R&D

High-throughput screening, AI-driven drug discovery, and targeted therapeutic development focusing on oncology, neurodegenerative diseases, and autoimmune conditions.

Genomics & Precision Medicine

Next-generation sequencing platforms, CRISPR-based therapies, and pharmacogenomic profiling to enable patient-specific treatment protocols.

Medical Devices & AI Diagnostics

Minimally invasive surgical robots, wearable biosensors, and FDA-cleared AI imaging algorithms for early pathology detection.

Global Care Networks

Integrated hospital systems, telemedicine infrastructure, and supply chain logistics ensuring equitable access to specialized care.

Active Product & Service Platforms

Current commercial, pipeline, and research-stage initiatives.

Platform Name Therapeutic Area Stage Region
NeuroVax-9 Neurodegenerative / Alzheimer's Commercial North America, EU
OncoTarget Alpha Oncology / Solid Tumors Phase III Trials Global
GeneWeave CRISPR-12 Rare Genetic Disorders Pre-Clinical US, UK, Japan
CardioSync Monitor Cardiology / Remote Patient Monitoring Commercial APAC, LATAM
AeroMed Transport Critical Care Logistics Commercial 62 Countries

Recent Breakthroughs & Milestones

Key developments from our R&D divisions and academic partnerships.

Q3 2025
FDA Breakthrough Therapy Designation for OncoTarget Alpha
Successful Phase II results showing 78% progression-free survival in previously untreated melanoma patients.
Q2 2025
Launch of Zenth Genomics Cloud Platform
HIPAA-compliant distributed sequencing database enabling real-time pharmacogenomic matching for clinical partners.
Q1 2025
Acquisition of NovaBiosystems & Integration into MedTech Division
Expansion into microfluidics and point-of-care diagnostics, adding 14 patent portfolios and 3 manufacturing facilities.
Q4 2024
EMA Approval of NeuroVax-9
First authorized therapeutic in the EU targeting early-stage tau protein aggregation pathways.

Primary Research & Clinical Facilities

State-of-the-art infrastructure supporting discovery, manufacturing, and care delivery.

Zenth Advanced Therapeutics Lab

Cambridge, MA, USA
BSL-3/4 containment, automated high-throughput screening, 12,000 sqm cleanrooms. Focus: Gene therapy & viral vectors.

European Clinical Research Institute

Zurich, Switzerland
Multi-center trial coordination, pharmacovigilance hub, 200+ investigator sites. Focus: Phase I-III oncology & neurology.

APAC Biomanufacturing Complex

Suzhou, China
GMP-certified fill/finish, cell culture bioreactors, single-use tech integration. Capacity: 500M doses annually.

Telehealth & Data Operations Center

Dublin, Ireland
Cloud-native clinical data pipeline, AI diagnostics training, GDPR-compliant patient registry management.

Division Leadership

Executive team driving strategy, compliance, and scientific innovation.

EV
Dr. Elena Vance
President, Zenth Health Sciences
Former Chief Medical Officer at Pfizer. 20+ years in translational medicine and global regulatory strategy.
KR
Dr. Kenji Ross
Chief Scientific Officer
PhD in Molecular Biology from MIT. Pioneer in CRISPR delivery mechanisms and synthetic biology applications.
SP
Dr. Sarah Petrov
VP, Clinical Operations
Led multi-national trial networks for rare diseases. Expert in FDA/EMA cross-border compliance and patient recruitment.
MJ
Marcus Jensen
Director, Health Tech Integration
Background in healthcare AI and electronic health records. Bridges Zenth's tech division with clinical workflows.

Collaborate with Zenth Health Sciences

Explore partnership opportunities, clinical trial enrollment, B2B licensing, or institutional investment.

View Partnership Programs Contact Division Team